(Q33529392)

27 July 2017

Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer (English)

1 reference

27 July 2017

1 reference

Gennaro Ciliberto

11

0 references

author name string

Helenia Ansuini

1

1 reference

27 July 2017

Annalisa Meola

2

1 reference

27 July 2017

Zeynep Gunes

3

1 reference

27 July 2017

Valentina Paradisi

4

1 reference

27 July 2017

Monica Pezzanera

5

1 reference

27 July 2017

Stefano Acali

6

1 reference

27 July 2017

Claudia Santini

7

1 reference

27 July 2017

Alessandra Luzzago

8

1 reference

27 July 2017

Federica Mori

9

1 reference

27 July 2017

Domenico Lazzaro

10

1 reference

27 July 2017

Alfredo Nicosia

12

1 reference

27 July 2017

Nicola La Monica

13

1 reference

27 July 2017

Alessandra Vitelli

14

1 reference

27 July 2017

1 January 2009

1 reference

27 July 2017

1 reference

27 July 2017

2009

1 reference

27 July 2017

951917

1 reference

Creative Commons Attribution 3.0 Unported

27 July 2017

start time

1 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Eph, a protein family coming of age: more confusion, insight, or complexity?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Eph-ephrin bidirectional signaling in physiology and disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Eph-ephrin signalling in adult tissues and cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Differential screening of phage-ab libraries by oligonucleotide microarray technology.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

EphrinA1 activates a Src/focal adhesion kinase-mediated motility response leading to rho-dependent actino/myosin contractility

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Anti-EphA2 antibodies decrease EphA2 protein levels in murine CT26 colorectal and human MDA-231 breast tumors but do not inhibit tumor growth

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

A conditional feedback loop regulates Ras activity through EphA2.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Eph receptor signalling casts a wide net on cell behaviour

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

21 June 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

21 June 2018

https://api.crossref.org/works/10.1155%2F2009%2F951917

EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

21 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F951917

Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F951917

A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F951917

Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F951917

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F951917

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2009%2F951917

c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814375

31 October 2018

Identifiers

DOI

10.1155/2009/951917

1 reference

release_xr6jc6bgc5bkdfrdfrexqakfz4

27 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xr6jc6bgc5bkdfrdfrexqakfz4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

2814375

1 reference

27 July 2017

1 reference